Michael Gent

53.4k citations
247 papers · 42.7k · 23 hit papers · h-index 96

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Cardiac pacing and defibrillation studies
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Atrial Fibrillation Management and Outcomes
    • Acute Myocardial Infarction Research
    • Cardiac electrophysiology and arrhythmias

Papers in

Michael Gent

238 papers receiving 37.5k citations

Michael Gent's Hit Papers

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial 2009 · 788 citations
7880+11+23Years since publication5001k1.5k2k2.5k

Peers

Michael Gent
Comparison fields: 5 of 170
  • Internal Medicine 14.1k
  • Cardiology and Cardiovascular Medicine 13.1k
  • Hematology 4k
  • Epidemiology 4.9k
  • Rheumatology 1.1k
Replace John W. Eikelboom with:
John W. Eikelboom Canada
Gérald Simonneau France
Sam Schulman Canada
Martin H. Prins Netherlands
Irene Marthe Lang Austria
Richard C. Becker United States
Paolo Prandoni Italy
Elaine M. Hylek United States
Menno Volkert Huisman Netherlands
Nazzareno Galiè Italy
Michael Gent relative to John W. Eikelboom Canada John W. Eikelboom's profile →
Citations per field
00.5×1.5×
John W. Eikelboom · 1×
Citations per year

Countries citing papers authored by Michael Gent

Since Specialization
Citations

This map shows the geographic impact of Michael Gent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gent more than expected).

Fields of papers citing papers by Michael Gent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gent. The network helps show where Michael Gent may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Gent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Gent Line = papers co-authored together Michael Gent links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 247 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Hit paper breakdown →
19942860
2
Intra-arterial Prourokinase for Acute Ischemic Stroke
Hit paper breakdown →
19992415
3
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
Hit paper breakdown →
20032011
4
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
Hit paper breakdown →
19951895
5
Canadian Implantable Defibrillator Study (CIDS)
Hit paper breakdown →
20001215
6
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
Hit paper breakdown →
20041122
7
PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke
Hit paper breakdown →
1998984
8
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
Hit paper breakdown →
1996939
9
A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism
Hit paper breakdown →
1999880
10
Canadian atrial fibrillation anticoaguiation (CAFA) study
Hit paper breakdown →
1991879
11
Aspirin, Sulfinpyrazone, or Both in Unstable Angina
Hit paper breakdown →
1985871
12
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Hit paper breakdown →
2009788
13
Platelet-Active Drugs
Hit paper breakdown →
2001764
14
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
Hit paper breakdown →
2003709
15
THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Hit paper breakdown →
1989698
16
Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
Hit paper breakdown →
1997696
17
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
Hit paper breakdown →
2003613
18 2000602
19
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hit paper breakdown →
1982588
20
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
Hit paper breakdown →
1986588

About Michael Gent

Michael Gent is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Statistics and Probability and Epidemiology, having authored 247 papers that have together received 42.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (102 papers), Antiplatelet Therapy and Cardiovascular Diseases (35 papers), Cardiac pacing and defibrillation studies (19 papers), Acute Ischemic Stroke Management (18 papers), Acute Myocardial Infarction Research (14 papers), Statistical Methods in Clinical Trials (11 papers), Platelet Disorders and Treatments (11 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). The work is most often cited by research in Internal Medicine (14.1k citations), Cardiology and Cardiovascular Medicine (13.1k citations), Hematology (4k citations), Epidemiology (4.9k citations) and Rheumatology (1.1k citations). Michael Gent has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jack Hirsh, Stuart J. Connolly, Robin S. Roberts, Mark N. Levine, John A. Cairns, Jim A. Julian, David L. Sackett, Paul Dorian, Randall T. Higashida and Howard A. Rowley. Their work appears in journals such as New England Journal of Medicine, Circulation, Thrombosis and Haemostasis, The Lancet and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact